MwanzoIDP • ETR
add
Biogen Inc
Bei iliyotangulia
€ 154.75
Bei za siku
€ 151.35 - € 154.05
Bei za mwaka
€ 146.40 - € 245.60
Thamani ya kampuni katika soko
23.42B USD
Wastani wa hisa zilizouzwa
398.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.47B | -2.55% |
Matumizi ya uendeshaji wa biashara | 1.32B | -17.78% |
Mapato halisi | 388.50M | 670.48% |
Kiwango cha faida halisi | 15.76 | 685.87% |
Mapato kwa kila hisa | 4.08 | -6.42% |
EBITDA | 694.20M | 75.52% |
Asilimia ya kodi ya mapato | 13.86% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.70B | -25.73% |
Jumla ya mali | 28.31B | 0.43% |
Jumla ya dhima | 11.95B | -12.83% |
Jumla ya hisa | 16.36B | — |
hisa zilizosalia | 145.72M | — |
Uwiano wa bei na thamani | 1.38 | — |
Faida inayotokana na mali | 4.64% | — |
Faida inayotokana mtaji | 5.61% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 388.50M | 670.48% |
Pesa kutokana na shughuli | 935.60M | 57.93% |
Pesa kutokana na uwekezaji | -1.18B | 32.21% |
Pesa kutokana na ufadhili | -6.60M | -100.78% |
Mabadiliko halisi ya pesa taslimu | -209.70M | 36.44% |
Mtiririko huru wa pesa | 997.75M | 617.87% |
Kuhusu
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1978
Makao Makuu
Tovuti
Wafanyakazi
7,570
